PAA
PFE icon

Peregrine Asset Advisers’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,522
Closed -$216K 173
2023
Q3
$216K Buy
+6,522
New +$216K 0.11% 137
2022
Q3
Sell
-9,190
Closed -$482K 79
2022
Q2
$482K Sell
9,190
-47,546
-84% -$2.49M 0.35% 44
2022
Q1
$2.94M Sell
56,736
-63,841
-53% -$3.3M 1.5% 27
2021
Q4
$7.12M Buy
120,577
+1,125
+0.9% +$66.4K 2.9% 6
2021
Q3
$5.14M Buy
119,452
+5,939
+5% +$255K 2.62% 9
2021
Q2
$4.45M Sell
113,513
-134
-0.1% -$5.25K 2.02% 15
2021
Q1
$4.12M Sell
113,647
-4,218
-4% -$153K 2.1% 16
2020
Q4
$4.34M Sell
117,865
-1,676
-1% -$61.7K 2.03% 13
2020
Q3
$4.39M Buy
119,541
+95,114
+389% +$3.49M 2.41% 12
2020
Q2
$799K Buy
24,427
+17,871
+273% +$585K 0.45% 44
2020
Q1
$214K Buy
6,556
+29
+0.4% +$947 0.16% 77
2019
Q4
$256 Sell
6,527
-353
-5% -$14 0.06% 93
2019
Q3
$247K Buy
6,880
+30
+0.4% +$1.08K 0.14% 84
2019
Q2
$297K Buy
6,850
+26
+0.4% +$1.13K 0.15% 90
2019
Q1
$290K Buy
6,824
+24
+0.4% +$1.02K 0.17% 85
2018
Q4
$297K Sell
6,800
-169
-2% -$7.38K 0.39% 53
2018
Q3
$307K Buy
6,969
+215
+3% +$9.47K 0.14% 89
2018
Q2
$245K Buy
6,754
+27
+0.4% +$979 0.13% 95
2018
Q1
$239K Buy
6,727
+27
+0.4% +$959 0.16% 86
2017
Q4
$243K Buy
6,700
+25
+0.4% +$907 0.12% 89
2017
Q3
$238K Sell
6,675
-679
-9% -$24.2K 0.13% 77
2017
Q2
$247K Buy
7,354
+35
+0.5% +$1.18K 0.16% 70
2017
Q1
$250K Buy
7,319
+32
+0.4% +$1.09K 0.13% 73
2016
Q4
$237K Buy
7,287
+33
+0.5% +$1.07K 0.14% 90
2016
Q3
$246K Buy
7,254
+29
+0.4% +$983 0.15% 90
2016
Q2
$254K Buy
7,225
+29
+0.4% +$1.02K 0.17% 87
2016
Q1
$213K Sell
7,196
-207
-3% -$6.13K 0.16% 93
2015
Q4
$239K Sell
7,403
-1,403
-16% -$45.3K 0.21% 77
2015
Q3
$277K Buy
8,806
+28
+0.3% +$881 0.28% 65
2015
Q2
$294K Sell
8,778
-90
-1% -$3.01K 0.22% 77
2015
Q1
$309K Buy
8,868
+1,459
+20% +$50.8K 0.2% 89
2014
Q4
$231K Buy
7,409
+28
+0.4% +$873 0.16% 102
2014
Q3
$218K Sell
7,381
-235
-3% -$6.94K 0.18% 98
2014
Q2
$226K Buy
7,616
+27
+0.4% +$801 0.2% 99
2014
Q1
$244K Buy
7,589
+26
+0.3% +$836 0.19% 93
2013
Q4
$232K Buy
7,563
+23
+0.3% +$706 0.2% 94
2013
Q3
$217K Buy
7,540
+26
+0.3% +$748 0.21% 127
2013
Q2
$210K Buy
+7,514
New +$210K 0.22% 118